Belpointe Asset Management LLC Tg Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

  • $1.51 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$10.23 - $19.34 $47,610 - $90,008
4,654 Added 222.04%
6,750 $101,000
Q4 2022

Feb 08, 2023
BUY
$5.01 - $11.83 $10,500 - $24,795
2,096 New
2,096 $24,000
Q4 2018

Mar 06, 2019
SELL
$3.44 - $5.76 $149,416 - $250,185
-43,435 Closed
0 $0
Q3 2018

Nov 23, 2018
BUY
$5.15 - $14.0 $223,690 - $608,090
43,435 New
43,435 $243,000

Others Institutions Holding TGTX

# of Institutions
373
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $6.17B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email